Early Time-Restricted Eating in Young Judo Athletes (TRE-JUDO)
Effects of a 5-Month Early Time-Restricted Eating Protocol on Body Composition, Muscle Damage Biomarkers, Competitive Anxiety, and Self-Confidence in Highly Trained Young Judo Athletes: A Randomized Controlled Trial
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This study was designed to evaluate the effects of a 5-month early time-restricted eating (e-TRE) intervention on physiological and psychological outcomes in highly trained young male judo athletes. The study included 100 participants recruited from competitive judo teams in Tunisia. Participants were randomly assigned to either an e-TRE group or a control group in a 1:1 ratio.
The e-TRE group followed a structured 16:8 time-restricted eating protocol, consuming all daily energy intake within an 8-hour window from 07:00 to 15:00, followed by a 16-hour fasting period. During fasting hours, only non-caloric beverages were permitted. The control group maintained their habitual dietary intake and meal timing without any modifications. Both groups continued their regular judo training program, consisting of 5-6 training sessions per week, including technical drills, sparring (randori), and strength and conditioning exercises.
Anthropometric and biochemical measurements were collected at baseline (T0) and after the 5-month intervention (T1). Psychological assessments were conducted before monthly competitions throughout the study period. Blood samples were collected under standardized resting conditions and analyzed using validated enzymatic and immunoassay techniques.
Participants were required to meet strict inclusion criteria, including age 18-26 years, male sex, at least 3 years of judo training experience, and absence of metabolic, psychiatric, or chronic diseases. Exclusion criteria included use of medications or supplements affecting metabolism, prior experience with intermittent fasting, and conditions that could affect training or biomarker outcomes.
The study was approved by the Ethics Committee of the Higher Institute of Sport and Physical Education of Ksar Said, University of Manouba, Tunisia (approval No. 0171823; organization's unique protocol ID: ISSEP-2026-023) and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to enrollment
Statistical analyses included repeated-measures ANOVA to assess group × time effects, with significance set at p < 0.05. Effect sizes were calculated using partial eta squared (η²).
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Manouba
-
Manouba, Manouba, Túnez, 2009
- Higher Institute of Sport and Physical Education of Manouba (ISSEP Manouba)
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- aged 19-26 years;
- male judo players; c) with at least 3 years of judo training experience;
- engaged in judo training 5-6 days per week; e) healthy, with no known chronic illnesses or conditions affecting metabolism, mental health, or physical performance;
- willing to adhere to a 16:8 e-TRE protocol for the 5-month study period;
- non-smokers, as smoking may affect anxiety levels and cardiovascular health;
- not using any performance-enhancing drugs or supplements that could interfere with the study's measurements.
Exclusion Criteria:
- current musculoskeletal injuries or conditions that could limit participation in training or affect muscle damage biomarkers;
- diagnosed psychiatric disorders or current treatment for anxiety or mood disorders, as these could interfere with psychological assessments;
- use of medications affecting metabolism, muscle recovery, or psychological state (e.g., corticosteroids, antidepressants);
- prior experience with time-restricted eating or intermittent fasting within the past year, as prior adaptation could impact study outcomes;
- dietary restrictions or practices (e.g., vegan or keto diet) that could affect nutrient intake or metabolic markers;
- diagnosed sleep disorders or irregular sleep patterns, as sleep quality could impact both muscle recovery and psychological parameters;
- inability to commit to the structured training program over the study period.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Early Time-Restricted Eating (e-TRE) Group
Participants in this group followed a 16:8 early time-restricted eating protocol for 5 months.
Participants maintained their usual training program throughout the intervention period.
|
The intervention consisted of a 16:8 early time-restricted eating protocol applied for 5 months.
Participants consumed all meals between 07:00 and 15:00, followed by a fasting period from 15:00 to 07:00 the next day.
Only non-caloric beverages were allowed during fasting hours.
Participants continued their regular judo training (5-6 sessions per week) without modifications.
Dietary guidance was provided to support adherence to the eating schedule.
|
|
Sin intervención: Control Group
Participants in this group maintained their habitual dietary practices.
They continued their regular judo training program throughout the 5-month study period.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Competitive Anxiety and Self-Confidence
Periodo de tiempo: Baseline and 5 months (pre-intervention and post-intervention)
|
Competitive anxiety and self-confidence will be assessed using the Competitive State Anxiety Inventory-2 (CSAI-2). This validated questionnaire measures three dimensions of pre-competition psychological state: cognitive anxiety, somatic anxiety, and self-confidence. Scores will be used to evaluate changes in athletes' psychological readiness, emotional response to competition, and perceived self-efficacy. The CSAI-2 consists of 27 items, divided into three subscales (9 items each). Each item is rated on a 4-point Likert scale ranging from 1 ("not at all") to 4 ("very much so"). Subscale scores are calculated by summing item responses, resulting in a score range of 9 to 36 for each dimension (cognitive anxiety, somatic anxiety, and self-confidence). Measurements will be taken at baseline (T0) and post-intervention (T1) to determine the effect of early time-restricted eating on competitive anxiety and self-confidence in young judo athletes. |
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Creatine kinase (CK)
Periodo de tiempo: Baseline and 5 months (pre-intervention and post-intervention)]
|
Creatine kinase (CK) will be used as a marker of muscle damage.
Blood samples will be collected to assess changes in CK levels in response to the early time-restricted eating intervention.
CK concentrations will be measured in U/L and compared between baseline (T0) and post-intervention (T1, 5 months) in judo athletes.
|
Baseline and 5 months (pre-intervention and post-intervention)]
|
|
Lactate dehydrogenase (LDH)
Periodo de tiempo: Baseline and 5 months (pre-intervention and post-intervention)
|
Lactate dehydrogenase (LDH) will be used as a biomarker of muscle damage.
LDH will be measured in U/L to assess changes induced by early time-restricted eating between baseline and post-intervention in judo athletes.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Aspartate aminotransferase (AST)
Periodo de tiempo: Baseline and 5 months (pre-intervention and post-intervention)
|
Aspartate aminotransferase (AST) will be measured as an indirect marker of muscle damage and metabolic stress.
AST levels will be assessed in U/L to evaluate changes from baseline to post-intervention following early time-restricted eating in judo athletes.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Alanine aminotransferase (ALT)
Periodo de tiempo: Baseline and 5 months (pre-intervention and post-intervention)
|
Alanine aminotransferase (ALT) will be assessed as a biomarker related to muscle stress.
ALT levels will be measured in U/L to determine changes following early time-restricted eating between baseline and post-intervention in judo athletes.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Uric acid
Periodo de tiempo: Baseline and 5 months (pre-intervention and post-intervention)
|
Uric acid will be measured as a metabolic and oxidative stress biomarker.
Serum uric acid will be assessed in µmol/L to evaluate changes induced by early time-restricted eating in judo athletes.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
C-reactive protein (CRP)
Periodo de tiempo: Baseline and 5 months (pre-intervention and post-intervention)
|
C-reactive protein (CRP) will be used as a systemic inflammation biomarker.
CRP levels will be measured in mg/L to assess inflammatory response changes following early time-restricted eating between baseline and post-intervention in judo athletes.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Total bilirubin
Periodo de tiempo: Baseline and 5 months (pre-intervention and post-intervention)
|
Total bilirubin will be measured as a marker of oxidative stress and heme metabolism.
Serum bilirubin levels will be assessed in µmol/L to evaluate changes induced by early time-restricted eating in judo athletes between baseline and post-intervention.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Body Mass Index (BMI)
Periodo de tiempo: Baseline and 5 months (pre-intervention and post-intervention)
|
Body Mass Index (BMI) will be calculated as body weight in kilograms divided by height in meters squared (kg/m²).
BMI will be used to assess changes in overall body composition status following early time-restricted eating.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Body fat percentage
Periodo de tiempo: Baseline and 5 months (pre-intervention and post-intervention)
|
Body fat percentage will be assessed as an indicator of relative adiposity.
Body fat percentage will be expressed as a percentage (%) and measured to evaluate changes following the early time-restricted eating intervention.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Skeletal muscle mass
Periodo de tiempo: Baseline and 5 months (pre-intervention and post-intervention)
|
Skeletal muscle mass will be assessed as an indicator of lean muscle tissue.
Skeletal muscle mass will be measured in kilograms (kg) to evaluate changes induced by early time-restricted eating.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- ISSEP-2026-023
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .